Summary
Mononuclear cells from 12 normal controls (co), 10 advanced untreated (c1), and 6 advanced treated cancer patients (c2) have been isolated. The numbers of mononuclear cells bearing Leu1, Leu2, Leu3, Leu2/HLA-DR and LeuM3 were measured with a fluorescence-activated cell sorter. Only the quantity of helper T cells (Leu3) was decreased in cancer patients (co: 0.89, c1: 0.32, c2: 0.44 × 109/1). Expression of all other markers, including activated suppressor T cells (Leu2/HLA-DR), did not differ significantly from the control. The proliferation of the lymphocytes was determined in a phytohemagglutininculture assay. The cancer groups showed a significantly decreased response (co: 95.8 × 109, cl: 28.7 × 109, c2: 25.7 × 109 cpm). These values correlated with the number of helper T cells but not with the suppressor T cells. Monocytes of cancer patients adsorbed significantly more immunoglobulins than the monocytes of controls. The addition of indomethacin or isoprinosine to phytohemagglutinin-culture assay increased the proliferation of lymphocytes from both the cancer patients and normal controls.
References
Braun DP, Harris JE (1981) Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients. J Natl Cancer Inst 67: 809
Braun DP, Harris JE, Rubinstein M (1984) Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients. J Immunopharmacol 6: 227
Dillman RO, Koziol JA, Zanvelli MI, Beauregard JC, Halliburton BL, Glassy MC, Royston I (1984) Immunocompetence in cancer patients. Cancer 53: 1484
Han T, Nemoto T, Ledesma EJ, Bruno S (1983) Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients. Int J Immunopharmacol 5: 11
Hollander M, Wolfe DA (1973) Non-parametric statistical methods. Wiley, New York
Ludwig CU, Hartmann D, Landmann R, Wesp M, Rosenfelder G, Stucki D, Buser M, Obrecht JP (1985) Unaltered immunocompetence in patients with nondisseminated breast cancer at the time of diagnosis. Cancer 55: 1673
Meurer S, Hussey RE, Penta AC, Fitzgerald KA, Stadler BM, Schlossmann SF, Reinherz EL (1982) Cellular origin of interleukin 2 (IL2) in man: evidence for stimulus restricted IL2 production by T4+ and T8+ T lymphocytes. J Immunol 129: 1076
Mire-Sluis AR, Wickremasinghe RG, Hoffbrand AV, Timms AM, Gillian E (1987) Human T lymphocytes stimulated by phytohemagglutinin undergo a single round of cell division without a requirement for interleukin-2 or accessory cells. Immunology 60: 7
Stepeleswski Z, Lubeck MD, Koprowski H (1983) Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells. Science 221: 865
Tax WJM, Willems HW, Reekers PPM, Capel PJA, Koenen RAP (1983) Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304: 445
Tsang PH, Zanjani MD, Warner N, Bekesi JG (1986) Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and aids patients. J Clin Lab Immunol 20: 159
Von Roenn J, Harris JE, Braun DP (1987) Suppressor cell function in solid tumor cancer patients. J Clin Oncol 5: 150
Wanebo HJ, Pace R, Hargett S, Katz D, Sando J (1986) Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer 57: 656
Wiranowska-Stewart M, Hadden JW (1986) Effects of isoprinosine and MPT 15 392 on interleukin-2 (IL-2) production. Int J Immunopharmacol 8: 63
Zembala M, Uracz W, Ruggiero I, Mytar B, Pryjma J (1984) Isolation and functional characteristics of FcR+ and FcR− human monocytes subsets. J Immunol 133: 1293
Author information
Authors and Affiliations
Additional information
Supported by the Swiss National Science Foundation
Rights and permissions
About this article
Cite this article
Richner, J., Ambinder, E.P., Hoffmann, K. et al. Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients. Cancer Immunol Immunother 34, 138–142 (1991). https://doi.org/10.1007/BF01741349
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741349